Hormonal and reproductive factors and risk of glioma

A prospective cohort study

Stephanie A. Navarro Silvera, Anthony B. Miller, Thomas E. Rohan

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The etiology of glioma, the most commonly diagnosed malignant brain tumor among adults in the United States, is poorly understood. Given the lower incidence rate of glioma in women than in men, it has been hypothesized that reproductive and hormonal factors may be involved in the etiology of glioma. We conducted a secondary analysis of data from the National Breast Screening Study, which included 89,835 Canadian women, aged 40-59 years at recruitment between 1980 and 1985. Linkages to national cancer and mortality databases yielded data on cancer incidence and deaths from all causes, respectively, with follow-up ending between 1998 and 2000. Cox proportional hazards models were used to estimate hazard ratios and 95% confidence intervals (CI) for the association between hormonal and reproductive factors and risk of glioma. During a mean of 16.4 years of follow-up, we observed 120 incident glioma cases. Compared with women with a relatively early age at menarche (≤12 years), women who were 13-14 years of age at menarche had a 64% increased risk of glioma (95% CI = 1.01-2.65), and women who were older than 14 years of age at menarche had a 66% increased risk of glioma (95% CI = 0.86-3.20, ptrend = 0.06). Age at first live birth, parity, menopausal status, use of oral contraceptive and use of hormone replacement therapy were not associated with altered glioma risk in our study population. Additional prospective studies are needed to confirm our findings.

Original languageEnglish (US)
Pages (from-to)1321-1324
Number of pages4
JournalInternational Journal of Cancer
Volume118
Issue number5
DOIs
StatePublished - Mar 1 2006

Fingerprint

Glioma
Cohort Studies
Prospective Studies
Menarche
Confidence Intervals
Birth Order
Incidence
Hormone Replacement Therapy
Live Birth
Oral Contraceptives
Parity
Proportional Hazards Models
Brain Neoplasms
Cause of Death
Neoplasms
Breast
Databases
Mortality
Population

Keywords

  • Brain neoplasms
  • Cohort
  • Glioma
  • Hormones
  • Reproductive factors

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Hormonal and reproductive factors and risk of glioma : A prospective cohort study. / Navarro Silvera, Stephanie A.; Miller, Anthony B.; Rohan, Thomas E.

In: International Journal of Cancer, Vol. 118, No. 5, 01.03.2006, p. 1321-1324.

Research output: Contribution to journalArticle

Navarro Silvera, Stephanie A. ; Miller, Anthony B. ; Rohan, Thomas E. / Hormonal and reproductive factors and risk of glioma : A prospective cohort study. In: International Journal of Cancer. 2006 ; Vol. 118, No. 5. pp. 1321-1324.
@article{a2b7aaa385254092b00bfb3e054e65c7,
title = "Hormonal and reproductive factors and risk of glioma: A prospective cohort study",
abstract = "The etiology of glioma, the most commonly diagnosed malignant brain tumor among adults in the United States, is poorly understood. Given the lower incidence rate of glioma in women than in men, it has been hypothesized that reproductive and hormonal factors may be involved in the etiology of glioma. We conducted a secondary analysis of data from the National Breast Screening Study, which included 89,835 Canadian women, aged 40-59 years at recruitment between 1980 and 1985. Linkages to national cancer and mortality databases yielded data on cancer incidence and deaths from all causes, respectively, with follow-up ending between 1998 and 2000. Cox proportional hazards models were used to estimate hazard ratios and 95{\%} confidence intervals (CI) for the association between hormonal and reproductive factors and risk of glioma. During a mean of 16.4 years of follow-up, we observed 120 incident glioma cases. Compared with women with a relatively early age at menarche (≤12 years), women who were 13-14 years of age at menarche had a 64{\%} increased risk of glioma (95{\%} CI = 1.01-2.65), and women who were older than 14 years of age at menarche had a 66{\%} increased risk of glioma (95{\%} CI = 0.86-3.20, ptrend = 0.06). Age at first live birth, parity, menopausal status, use of oral contraceptive and use of hormone replacement therapy were not associated with altered glioma risk in our study population. Additional prospective studies are needed to confirm our findings.",
keywords = "Brain neoplasms, Cohort, Glioma, Hormones, Reproductive factors",
author = "{Navarro Silvera}, {Stephanie A.} and Miller, {Anthony B.} and Rohan, {Thomas E.}",
year = "2006",
month = "3",
day = "1",
doi = "10.1002/ijc.21467",
language = "English (US)",
volume = "118",
pages = "1321--1324",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Hormonal and reproductive factors and risk of glioma

T2 - A prospective cohort study

AU - Navarro Silvera, Stephanie A.

AU - Miller, Anthony B.

AU - Rohan, Thomas E.

PY - 2006/3/1

Y1 - 2006/3/1

N2 - The etiology of glioma, the most commonly diagnosed malignant brain tumor among adults in the United States, is poorly understood. Given the lower incidence rate of glioma in women than in men, it has been hypothesized that reproductive and hormonal factors may be involved in the etiology of glioma. We conducted a secondary analysis of data from the National Breast Screening Study, which included 89,835 Canadian women, aged 40-59 years at recruitment between 1980 and 1985. Linkages to national cancer and mortality databases yielded data on cancer incidence and deaths from all causes, respectively, with follow-up ending between 1998 and 2000. Cox proportional hazards models were used to estimate hazard ratios and 95% confidence intervals (CI) for the association between hormonal and reproductive factors and risk of glioma. During a mean of 16.4 years of follow-up, we observed 120 incident glioma cases. Compared with women with a relatively early age at menarche (≤12 years), women who were 13-14 years of age at menarche had a 64% increased risk of glioma (95% CI = 1.01-2.65), and women who were older than 14 years of age at menarche had a 66% increased risk of glioma (95% CI = 0.86-3.20, ptrend = 0.06). Age at first live birth, parity, menopausal status, use of oral contraceptive and use of hormone replacement therapy were not associated with altered glioma risk in our study population. Additional prospective studies are needed to confirm our findings.

AB - The etiology of glioma, the most commonly diagnosed malignant brain tumor among adults in the United States, is poorly understood. Given the lower incidence rate of glioma in women than in men, it has been hypothesized that reproductive and hormonal factors may be involved in the etiology of glioma. We conducted a secondary analysis of data from the National Breast Screening Study, which included 89,835 Canadian women, aged 40-59 years at recruitment between 1980 and 1985. Linkages to national cancer and mortality databases yielded data on cancer incidence and deaths from all causes, respectively, with follow-up ending between 1998 and 2000. Cox proportional hazards models were used to estimate hazard ratios and 95% confidence intervals (CI) for the association between hormonal and reproductive factors and risk of glioma. During a mean of 16.4 years of follow-up, we observed 120 incident glioma cases. Compared with women with a relatively early age at menarche (≤12 years), women who were 13-14 years of age at menarche had a 64% increased risk of glioma (95% CI = 1.01-2.65), and women who were older than 14 years of age at menarche had a 66% increased risk of glioma (95% CI = 0.86-3.20, ptrend = 0.06). Age at first live birth, parity, menopausal status, use of oral contraceptive and use of hormone replacement therapy were not associated with altered glioma risk in our study population. Additional prospective studies are needed to confirm our findings.

KW - Brain neoplasms

KW - Cohort

KW - Glioma

KW - Hormones

KW - Reproductive factors

UR - http://www.scopus.com/inward/record.url?scp=31844454641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31844454641&partnerID=8YFLogxK

U2 - 10.1002/ijc.21467

DO - 10.1002/ijc.21467

M3 - Article

VL - 118

SP - 1321

EP - 1324

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 5

ER -